Integral-Health-Asset-Management
AI_NATIVE detailed information: This accession holds the following tickers:[ "ASND", "EWTX", "RGEN", "ALKS", "INSM", "KRYS", "RVMD", "INSP", "RDNT", "MASI", "ALHC", "ACHC", "ABBV", "ARWR", "PTCT", "ALNY", "FMS", "BSX", "MREO", "EHC", "RGNX", "TERN", "NRIX", "MLYS", "GILD", "ANRO", "BTSG", "SRRK", "OSCR", "FATE", "SANA", "TARS", "NBIX", "JSPR", "PTN", "IQV", "ATYR", "TARA", "RZLT", "MDT", "NVS", "TEVA", "GEHC", "PFE", "CI", "RNA", "TENX", "MLTX", "ACLX", "QURE", "ETNB", "DYN", "GMED", "EW", "PEN", "THC", "ROIV", "VRNA", "VSTM", "VKTX", "WAT", "XENE", "VERA", "BHVN", "LH", "MCK", "BAX", "BDX", "BNTX", "BPMC", "BMY", "BBIO", "CABA", "CPRX", "CRNX", "CRSP", "CVS", "CYTK", "DXCM", "ELV" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 80
- Total Value
- 933236100
- Accession Number
- 0001172661-25-001939
- Form Type
- 13F-HR
- Manager Name
- Integral-Health-Asset-Management
Data Enrichment
100% identified80 identified0 unidentified
Holdings
80 positions • $933.2M total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
Shares:150.0K
Value:$3.6M
% of Portfolio:0.4% ($3.6M/$933.2M)
Shares:175.0K
Value:$2.2M
% of Portfolio:0.2% ($2.2M/$933.2M)
Shares:700.0K
Value:$1.9M
% of Portfolio:0.2% ($1.9M/$933.2M)
Shares:400.0K
Value:$864.0K
% of Portfolio:0.1% ($864.0K/$933.2M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
BioNTech SE(BNTXcusip09075V102) | 40.0K | YoY NEW(+40.0K) | All Managers (Combined) | $3.6M | 0.4% ($3.6M/$933.2M) | YoY NEW(+$3.6M) |
150.0K | YoY NEW(+150.0K) | All Managers (Combined) | $3.6M | 0.4% ($3.6M/$933.2M) | YoY NEW(+$3.6M) | |
100.0K | QoQ NEW(+100.0K) YoY NEW(+100.0K) | All Managers (Combined) | $3.5M | 0.4% ($3.5M/$933.2M) | QoQ NEW(+$3.5M) YoY NEW(+$3.5M) | |
2.0M | QoQ 0.00% (+0) | All Managers (Combined) | $3.4M | 0.4% ($3.4M/$933.2M) | ||
Cigna Group(CIcusip125523100) | 10.0K | QoQ NEW(+10.0K) | All Managers (Combined) | $3.3M | 0.4% ($3.3M/$933.2M) | QoQ NEW(+$3.3M) |
275.0K | YoY NEW(+275.0K) | All Managers (Combined) | $3.3M | 0.4% ($3.3M/$933.2M) | YoY NEW(+$3.3M) | |
Verastem, Inc.(VSTMcusip92337C203) | 500.0K | QoQ NEW(+500.0K) YoY NEW(+500.0K) | All Managers (Combined) | $3.0M | 0.3% ($3.0M/$933.2M) | QoQ NEW(+$3.0M) YoY NEW(+$3.0M) |
200.0K | All Managers (Combined) | $2.6M | 0.3% ($2.6M/$933.2M) | |||
REPLIGEN CORP(RGENcusip759916109) | 20.0K | All Managers (Combined) | $2.5M | 0.3% ($2.5M/$933.2M) | ||
575.0K | YoY NEW(+575.0K) | All Managers (Combined) | $2.5M | 0.3% ($2.5M/$933.2M) | YoY NEW(+$2.5M) | |
175.0K | YoY NEW(+175.0K) | All Managers (Combined) | $2.2M | 0.2% ($2.2M/$933.2M) | YoY NEW(+$2.2M) | |
aTYR PHARMA INC(ATYRcusip002120202) | 700.0K | YoY NEW(+700.0K) | All Managers (Combined) | $2.1M | 0.2% ($2.1M/$933.2M) | YoY NEW(+$2.1M) |
700.0K | YoY NEW(+700.0K) | All Managers (Combined) | $1.9M | 0.2% ($1.9M/$933.2M) | YoY NEW(+$1.9M) | |
800.0K | All Managers (Combined) | $1.8M | 0.2% ($1.8M/$933.2M) | |||
Rezolute, Inc.(RZLTcusip76200L309) | 500.0K | QoQ 0.00% (-0)YoY NEW(+500.0K) | All Managers (Combined) | $1.4M | 0.2% ($1.4M/$933.2M) | YoY NEW(+$1.4M) |
850.0K | All Managers (Combined) | $1.2M | 0.1% ($1.2M/$933.2M) | |||
167.0K | QoQ NEW(+167.0K) YoY NEW(+167.0K) | All Managers (Combined) | $1.1M | 0.1% ($1.1M/$933.2M) | QoQ NEW(+$1.1M) YoY NEW(+$1.1M) | |
400.0K | YoY NEW(+400.0K) | All Managers (Combined) | $864.0K | 0.1% ($864.0K/$933.2M) | YoY NEW(+$864.0K) | |
1.0M | QoQ NEW(+1.0M) YoY NEW(+1.0M) | All Managers (Combined) | $582.9K | 0.1% ($582.9K/$933.2M) | QoQ NEW(+$582.9K) YoY NEW(+$582.9K) | |
700.0K | All Managers (Combined) | $553.1K | 0.1% ($553.1K/$933.2M) |